|
Resolution: standard / high Figure 2.
T-cell proliferative responses in patients with juvenile idiopathic arthritis (JIA)
and healthy controls. Proliferative responses are presented as interquartile range
for each group of data, with horizontal lines showing the median. The aggrecan and
fibrillin peptides induced significant differences in responses of peripheral blood
mononuclear cells (PBMC) from patients with JIA and healthy controls and are indicated
as follows: **p = 0.005, *p = 0.015. The matrix metalloproteinase (MMP)-3 peptide induced proliferative responses
in PBMC of patients with JIA as well as in PBMC of controls. Transparent boxes: JIA;
gray boxes: healthy controls.
Kamphuis et al. Arthritis Research & Therapy 2006 8:R178 doi:10.1186/ar2088 |